Elan Pharmaceuticals , Inc.

Industry:	Pharmaceuticals, Drug Manufacturing & Research, Biotechnology
Revenues:	$92.2 Million
Employees:	727

Description

Elan Pharmaceuticals, Inc. is a wholly-owned subsidiary of Elan Corporation, plc (NYSE: ELAN). Elan is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York, London and Dublin Stock Exchanges.

Find More Jobs

Job Openings

Associate Director, Clinical Development (Medical South San Francisco , CA

Director, Operations - Global Pharmacovigilance an South San Francisco , CA

Sr. Medical Director South San Francisco , CA

Director, Operations - Global Pharmacovigilance and Risk Management South San Francisco , CA

Global Pharmacovigilance and Risk Management, Director of Operatons South San Francisco , CA

News Archive

Patent No. 07601528 Issued on Oct. 13, Assigned to Elan Pharmaceuticals, Inc. for Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease US Fed News Service, Including US State News; 10/15/2009 ...s disease .The inventors were issued U.S. Patent No. 07601528 on Oct. 13. The patent has been assigned Elan Pharmaceuticals, Inc., South San Francisco. According to the abstract released by the U.S. Patent & Trademark Office... ...more

Zacks Bull and Bear of the Day Highlights: VimpelCom, Rite Aid Corporation, Johnson & Johnson, Elan Pharmaceuticals and Gilead Sciences, Inc. Zacks Investment Research -; 10/14/2009 ...Johnson & Johnson, Elan Pharmaceuticals and Gilead Sciences, Inc...Johnson & Johnson ( ), Elan Pharmaceuticals ( ) and Gilead Sciences...acquired an 18.4% stake in Elan Pharmaceuticals ( ) for $885 million and... ...more

Zacks Bull and Bear of the Day Highlights: VimpelCom, Rite Aid Corporation, Johnson & Johnson, Elan Pharmaceuticals and Gilead Sciences, Inc. Business Wire; 10/14/2009 ...analysis on Johnson & Johnson (NYSE: JNJ), Elan Pharmaceuticals (NYSE: ELN) and Gilead Sciences, Inc. (Nasdaq...company recently acquired an 18.4% stake in Elan Pharmaceuticals (NYSE: ELN) for $885 million and an additional... ...more